Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia

NCT00789698 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Schizophrenia

Interventions

DRUG: Lurasidone HC1
DRUG: Quetiapine XR

Sponsor

Sumitomo Pharma America, Inc.